Bonifraterskie Centrum Medyczne Sp. z o.o.
- Address
- lock Available on a paid plan
Digestive System Diseases
At Bonifraterskie Centrum Medyczne Sp. z o.o. in Lodz, clinical research in digestive system diseases focuses mainly on ulcerative colitis, Crohn’s disease, and erosive esophagitis linked to gastroesophageal reflux disease. These studies are designed to assess how well new treatments can bring symptoms under control, improve healing, and support longer-term disease management.
- Testing new options for inducing remission in ulcerative colitis
- Evaluating safety and tolerability in inflammatory bowel disease
- Comparing treatments for healing and maintenance in erosive esophagitis
The site’s Endoscopy Department is part of this work, supporting research that aims to improve care for people with chronic gastrointestinal conditions.
Eye Diseases
Research in eye diseases at this hospital includes studies in atrophic age-related macular degeneration, a condition that can gradually affect central vision. The main goal is to evaluate whether new therapies may help slow disease progression and preserve sight.
- Studying treatment effectiveness in geographic atrophy associated with AMD
- Assessing potential to slow vision loss in age-related macular degeneration
This area of research reflects a broader effort to improve options for people living with chronic retinal disease.
Immune System Phenomena
Clinical trials in immune system phenomena at Szpital Zakonu Bonifratrów św. Jana Bożego w Łodzi are closely connected to ulcerative colitis and related inflammatory bowel disease. These studies explore whether newer immune-targeted treatments can help patients achieve remission and maintain better disease control over time.
- Evaluating immune-based therapies for ulcerative colitis
- Measuring remission outcomes in chronic inflammatory disease
- Checking long-term safety of novel immune-modulating approaches
The research combines symptom relief goals with careful attention to treatment safety and durability.
Ocular Physiological Phenomena
Studies in ocular physiological phenomena focus on how new treatments may affect the structure and function of the eye in atrophic AMD. The emphasis is on understanding whether investigational therapies can help protect retinal health and improve outcomes for patients with progressive vision loss.
- Assessing changes in retinal degeneration
- Evaluating approaches to preserve visual function
- Exploring treatment impact in macular disease
These trials support a more detailed understanding of eye function in degenerative retinal conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 of 6 therapeutic areas and 15 of 32 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Bonifraterskie Centrum Medyczne Sp. z o.o.
lock Showing 1 of 14 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A randomized, double-blind, multicenter phase III study to evaluate the long-term efficacy and safety of ABX464 25 mg or 50 mg once daily as a maintenance therapy in subjects with moderately to severely active ulcerative colitis | Abivax | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 32 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Obefazimod | 3 | Unknown | 2023-06-12 | 2023-06-12 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.